IGF::OT::IGF: Phase I SBIR Contract - FY17 - Topic 363 - Connecting Cancer Caregivers to Care Teams: Digital Platforms to Support Informal Cancer Caregiving
IGF::OT::IGF:第一阶段 SBIR 合同 - 2017 财年 - 主题 363 - 将癌症护理人员与护理团队联系起来:支持非正式癌症护理的数字平台
基本信息
- 批准号:9573428
- 负责人:
- 金额:$ 22.5万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-18 至 2018-06-17
- 项目状态:已结题
- 来源:
- 关键词:AddressCancer PatientCaregiver supportCaregiversCaringCommunicationCommunitiesContractsDevelopmentEducationElectronic Health RecordEmotionalEvaluationFailureFeedbackFocus GroupsGoalsHome environmentMalignant NeoplasmsPatientsPhaseProcessProviderPsyche structureReportingSelf CareSmall Business Innovation Research GrantSupport SystemSymptomsSystemTestingUnited StatesWorkbasecancer carecaregivingdesigndigitalexperiencehigh riskinformal supportpeerprototypesocialsuccessusability
项目摘要
The myCare2 solution will be marketed to cancer care organizations and include three separate portals for cancer caregivers, patients and providers. The system will be mobile-enabled and support standards-based EHR integration. Primary myCare2 features include symptom assessment, communication with the care team, care plan dissemination, tailored education content for caregiving and for caregiver self-care, and peer/community support.
The demands of caring for a cancer patient at home often result in a failure to meet caregivers’ personal and
emotional needs and place caregivers at high risk of experiencing a wide array of physical, mental and social
issues. Our overarching goal is to develop and evaluate myCare2, a dual-focused caregiver support system that
addresses the caregiving needs as well as the personal needs of a caregiver. The myCare2 solution will be
marketed to cancer care organizations and include three separate portals for cancer caregivers, patients and
providers. The system will be mobile-enabled and support standards-based EHR integration. Primary myCare2
features include symptom assessment, communication with the care team, care plan dissemination, tailored
education content for caregiving and for caregiver self-care, and peer/community support.
Our Phase I specific objectives are: 1) conduct a competitive analysis of features provided by other commercial
and academic caregiver support solutions; 2) collect feedback from stakeholders on system features, perceived
usefulness and potential barriers via focus groups; 3) develop the myCare2 prototype with a user-centric design
process leveraging our prior work; and 4) conduct usability tests with cancer patients, caregivers, and providers,
which we expect to demonstrate the usability and usefulness of our prototype.
myCare2解决方案将面向癌症护理机构销售,并包括针对癌症护理人员、患者和提供者的三个独立门户。该系统将支持移动设备,并支持基于标准的电子病历集成。myCare2的主要功能包括症状评估、与护理团队的沟通、护理计划的传播、为护理和护理者自我护理量身定制的教育内容,以及同伴/社区支持。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Niina Haas其他文献
Niina Haas的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Niina Haas', 18)}}的其他基金
Topic 384: CancerCostDetox: Detoxing Cancer Care Financial Toxicity
主题 384:CancerCostDetox:排毒癌症护理财务毒性
- 批准号:
10018202 - 财政年份:2019
- 资助金额:
$ 22.5万 - 项目类别:
相似海外基金
Research Project 2 Proteogenomic-guided therapeutic targeting of breast cancer patient-derived xenograft metastases
研究项目 2 蛋白质基因组引导的乳腺癌患者异种移植转移的治疗靶向
- 批准号:
10733315 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
SQLE and Sterols Contribute to Racial Disparity in ER+ Breast Cancer Patient Survival
SQLE 和甾醇导致 ER 乳腺癌患者生存率的种族差异
- 批准号:
10571020 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Establishing industrial production of components that enable expanding accessibility of PET imaging to cancer patient population.
建立组件的工业化生产,使癌症患者群体能够更容易地获得 PET 成像。
- 批准号:
10698218 - 财政年份:2023
- 资助金额:
$ 22.5万 - 项目类别:
Washington University PDX Development and Trial Center - Evaluation of Abemaciclib in Combination with Olaparib in Ovarian Cancer and Breast Cancer Patient-derived Xenograft Models
华盛顿大学 PDX 开发和试验中心 - Abemaciclib 联合 Olaparib 在卵巢癌和乳腺癌患者异种移植模型中的评估
- 批准号:
10582164 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10039823 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
EU-Funded
Convening a gynecologic cancer patient advisory group to adapt a digital health tool
召集妇科癌症患者咨询小组以采用数字健康工具
- 批准号:
460767 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
Miscellaneous Programs
Towards Cancer Patient Empowerment for Optimal Use of Antithrombotic Therapy at the End of Life
增强癌症患者在临终时最佳使用抗血栓治疗的能力
- 批准号:
10038000 - 财政年份:2022
- 资助金额:
$ 22.5万 - 项目类别:
EU-Funded
Longitudinal mixed method investigation of social networks and affective states as determinants of smoking behavior among cancer patient
社会网络和情感状态作为癌症患者吸烟行为决定因素的纵向混合方法调查
- 批准号:
10513670 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10598311 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:
Improving the translational value of head and neck cancer patient-in-mouse models
提高头颈癌小鼠模型的转化价值
- 批准号:
10442585 - 财政年份:2021
- 资助金额:
$ 22.5万 - 项目类别:














{{item.name}}会员




